Rhodacyanine Derivative Selectively Targets Cancer Cells and Overcomes Tamoxifen Resistance

John Koren(University of Florida), Chad A. Dickey(University of South Florida)
PLoS ONE
April 26, 2012
Cited by 51


Related Papers